{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/mrsa-in-primary-care/management/management/","result":{"pageContext":{"chapter":{"id":"ddb73bdb-86dd-524d-92b2-f92b0ca957a0","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field fa78ff50-6d9e-400c-8cd1-e14b28ad9b5b --><h2>Scenario: Management of MRSA in primary care</h2><!-- end field fa78ff50-6d9e-400c-8cd1-e14b28ad9b5b -->","summary":"Covers the management of meticillin-resistant Staphylococcus aureus (MRSA) in primary care.","htmlStringContent":"<!-- begin item 75fcb295-655c-45cd-8fd9-c79532fe4428 --><!-- begin field 6a42aa68-5826-499c-8000-acbc01590516 --><p>From birth onwards.</p><!-- end field 6a42aa68-5826-499c-8000-acbc01590516 --><!-- end item 75fcb295-655c-45cd-8fd9-c79532fe4428 -->","topic":{"id":"26f48611-f890-5112-aa26-bef13e5623e1","topicId":"c9e197be-4f79-4d67-bf67-2b2a8a137e03","topicName":"MRSA in primary care","slug":"mrsa-in-primary-care","lastRevised":"Last revised in October 2018","chapters":[{"id":"ba15ac05-528a-5474-8925-89cfea95b961","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"97d099f9-1263-51e7-8c71-fb82256182d3","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f6df2380-e42f-563b-8f75-a588376e1da7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"530a7f74-53c2-5e4e-8c1d-ceb01bccf776","slug":"changes","fullItemName":"Changes"},{"id":"a17267d5-eb08-5126-9312-b78fee4494a2","slug":"update","fullItemName":"Update"}]},{"id":"9537a389-c41a-5355-ac9c-9c56bba48a35","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"124fbaa7-2678-5958-b4be-d5f9be74c18a","slug":"goals","fullItemName":"Goals"},{"id":"4a1ce510-f22c-5132-a344-31bd40831eac","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5d44fe-1deb-51e2-bb59-04ccc35710c7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4b396bfd-befc-5055-a086-61c9628b6042","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"db6fe095-36c1-5949-87a9-e1c049f58234","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e5c4d5c6-ed37-5a97-a1ef-874a072dd190","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ab09ceb7-2cc4-57c7-a6ec-887e4df64336","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"25bf5688-a664-56d4-b6cd-077f06dc4be5","slug":"definition","fullItemName":"Definition"},{"id":"d85a2164-704c-52e3-b5f8-2170aa56ead6","slug":"causes","fullItemName":"Causes"},{"id":"06951cf4-8eb9-5dc4-89be-8f9d5c691a2c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e6f67db6-38d0-57cd-a3fa-15d68e43e3a3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"26204955-9976-5215-8ba5-fb73d7b50a95","slug":"complications","fullItemName":"Complications"}]},{"id":"41a2bada-cc7d-5a86-9495-82d662957b3a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d4b618cd-66fe-50a0-a686-99007ef42fc3","slug":"when-to-suspect-mrsa","fullItemName":"When to suspect MRSA"},{"id":"8c893fa3-9e5e-5db1-87f3-370e7e9afd70","slug":"assessment","fullItemName":"Assessment"},{"id":"01c6eee3-9b6f-5c05-8f49-c30279e03ddf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4d78ace1-1174-5c0f-b2e6-c74c8a51847a","fullItemName":"Management","slug":"management","subChapters":[{"id":"ddb73bdb-86dd-524d-92b2-f92b0ca957a0","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"a6c4d845-e78e-5116-b950-e78374132545","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9eb97cdf-d2a2-5018-9667-43dbca0cb266","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"ef38f185-0695-523f-bf60-bd75e123a75e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"aea98085-ac9a-5b4c-a54b-a8857e1055e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"795e0448-4ce8-5b2a-8a85-3aa1ecac9c40","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"834f64f0-6780-5945-914d-8f8a0d4e8dfe","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7c573460-655d-5212-8d3c-fb5758d25c43","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"43afc1fb-06c4-5ec8-9051-d49b5156cfc6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4d78ace1-1174-5c0f-b2e6-c74c8a51847a","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"39c0a3af-fa0e-5a91-9b4a-a3506d9f7a33","slug":"management-in-primary-care","fullItemName":"Management in primary care","depth":3,"htmlHeader":"<!-- begin field 73efeb2f-ecb0-466d-a49a-9c365db9f033 --><h3>How should I manage MRSA in primary care?</h3><!-- end field 73efeb2f-ecb0-466d-a49a-9c365db9f033 -->","summary":null,"htmlStringContent":"<!-- begin item d1569af5-c888-44d7-a865-8a137aeb82aa --><!-- begin field 46f80258-d5b7-460a-a283-dfab96433819 --><ul><li><strong>Follow appropriate infection control measures (in line with local policy) in all cases of suspected or confirmed MRSA infection.</strong><ul><li>Reducing transmission involves strict adherence to basic infection-control principles (particularly hand hygiene), whether a person is known to be colonized with meticillin-resistant <em>Staphylococcus aureus</em> (MRSA) or not, and careful communication between healthcare professionals.</li><li>Information on risk of MRSA should be appropriately documented and communicated between healthcare agencies (for example, on transfer of a person with MRSA into hospital or long-term care facility) —<strong> </strong>seek advice from the local infection control team if unsure.<ul><li>Mandatory reporting to Public Health England is currently required for all health care associated infection including those caused by meticillin-resistant <em>Staphylococcus aureus</em> (MRSA).</li></ul></li><li>National guidelines to support local infection control policies are available on line from:<ul><li>The National Institute for Health and Care Excellence (NICE) ‘<a href=\"https://www.nice.org.uk/guidance/CG139\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"c4b49337-9d8b-47e1-ae97-a98200ef0722\">Guidance on Healthcare-associated infections: prevention and control in primary and community care (CG139)</a>’.</li><li>The Department of Health and Social Care and Public Health England ‘<a href=\"https://www.gov.uk/government/publications/infection-prevention-and-control-in-care-homes-information-resource-published\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"2701bad8-6d74-4dab-9f23-a98200ef0862\">Care homes: infection prevention and control</a>’.</li></ul></li></ul></li><li><strong>Arrange urgent assessment in secondary care if the person has suspected or confirmed MRSA and:</strong><ul><li>Clinical features of severe or complicated infection (for example sepsis, endocarditis, pneumonia, osteomyelitis, joint infection, immunocompromise, multiple co-morbidities or at extremes of age).</li><li>Has an abscess requiring surgical intervention.</li></ul></li><li><strong>If the person has an uncomplicated skin/soft tissue or urinary tract infection without systemic features and MRSA is suspected or confirmed.</strong><ul><li>Discuss treatment (such as antibiotics and wound care) with a microbiologist or the local infection-control team (or follow local guidelines).<ul><li>Do not routinely treat with oral or topical antibiotics, unless directed by microbiology.</li></ul></li><li>Arrange follow up (after 48 hours [or sooner if worsening]) to monitor for signs of complications (such as sepsis, cellulitis, pneumonia, or osteomyelitis) and to ensure infection is resolving.</li></ul></li><li><strong>If the person is found to be an asymptomatic carrier of MRSA:</strong><ul><li>Decolonization is not routinely required for asymptomatic carriers of MRSA in the community but may be indicated if the person has <a class=\"topic-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/background-information/causes/\">risk factors</a> (such as a wound or invasive device, or is resident in a care home) – discuss the need for suppression therapy with the local infection-control team.<ul><li>Suppression treatment typically consists of an antibacterial solution for body and hair in addition to nasal treatment.</li><li>After completion of decolonization treatment, further screening or treatment is generally not required unless advised by the Infection Control team.</li></ul></li><li>Further information on decolonisation and products available can be obtained from the local Community Infection Prevention and Control or Public Health England Team.</li></ul></li><li><strong>Advise all people with confirmed MRSA:</strong><ul><li>That infection with MRSA does not present a risk to healthy people in the community MRSA.</li><li>To keep all wounds, cuts or breaks in the skin clean and covered with a dressing until healed and dry.<ul><li>If they are unable to keep the wound covered with a clean, dry dressing at all times, they should not participate in activities where they have skin to skin contact with other people (for example athletic activities) until their wound is healed.</li></ul></li><li>To wear disposable gloves when changing dressings and dispose of these and used dressings safely — gloves must never be re-used.</li><li>To wash their hands with soap and water regularly, especially before and after touching any dressings or wounds, even if gloves are worn — carers should wash their hands after any physical contact with an infected or colonised person.</li><li>To maintain good general hygiene with regular bathing and thorough laundering of clothes and bedding.</li><li>To avoid sharing items that may be contaminated such as towels, razors, toothbrushes, soaps, clothing, bedding, and athletic equipment.</li></ul></li></ul><!-- end field 46f80258-d5b7-460a-a283-dfab96433819 --><!-- end item d1569af5-c888-44d7-a865-8a137aeb82aa -->","subChapters":[{"id":"d6a2b4b6-c034-592f-a79b-843e56b8cc7d","slug":"basis-for-recommendation-480","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 35a0ac8f-8895-4f1f-9e1e-ad5d1762f642 --><h4>Basis for recommendation</h4><!-- end field 35a0ac8f-8895-4f1f-9e1e-ad5d1762f642 -->","summary":null,"htmlStringContent":"<!-- begin item 4807dd80-fd96-4132-9cb9-ad7560a043fd --><!-- begin field 5f098d9a-b51d-4617-86f7-1d5c5a8482fb --><p>The recommendations on the management of meticillin-resistant <em>Staphylococcus aureus</em> (MRSA) in primary care are based on the clinical guidelines <em>Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Nathwani et al, 2008</a>], <em>Healthcare-associated infections: prevention and control (PH36)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">NICE, 2011</a>], <em>Guidance on Healthcare-associated infections: prevention and control in primary and community care (CG139)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">NICE, 2012</a>], <em>Prevention and control methicillin-resistant Staphylococcus aureus (MRSA). National clinical guideline no. 2</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">An Roinn Slainte, 2013</a>], <em>Methicillin-resistant Staphyloccus aureus (MRSA)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">CDC, 2016</a>], <em>Community infection prevention and control guidance for general practice (also suitable for adoption by other healthcare providers, e.g. Dental Practice, Podiatry) MRSA </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Infection&nbsp;Prevention&nbsp;Control, 2017</a>] and <em>Management and treatment of common infections. Antibiotic guidance for primary care.</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">PHE, 2017</a>], the Department of Health expert advisory committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), 2014 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">ARHAI, 2014</a>], and expert opinion in a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Hay, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Taylor, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Ramakrishnan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">BMJ Best Practice, 2018</a>].</p><h5>Infection prevention and control measures</h5><ul><li>The recommendations on infection control measures are based on clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Nathwani et al, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">NICE, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">An Roinn Slainte, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">CDC, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Infection&nbsp;Prevention&nbsp;Control, 2017</a>].</li><li>Transmission of healthcare associated pathogens from one patient to another on the hands of healthcare workers is well established — good hand hygiene is an essential component of MRSA control [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">An Roinn Slainte, 2013</a>].</li><li>Mandatory reporting to Public Health England is required for all health care associated infections including those caused by MRSA [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">DH, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">NICE, 2016</a>].<ul><li>All cases of MRSA blood stream infection (MRSA BSI) must be reported to Public Health England (PHE) data capture system and a Post Infection Review (PIR) carried out to identify possible lapses in care and identify organisations best placed to ensure improvements are made.  From April 2018 the PIR has become a local process — when a case of MRSA BSI has been identified, the organisation from which the sample originated has the responsibility of ensuring that the full mandatory dataset is recorded on the Data Capture System (for example, in the case of a GP, the CCG is the responsible organisation and will involve any other provider organisation as necessary) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">DH, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Infection&nbsp;Prevention&nbsp;Control, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">NHS Improvement, 2018</a>].</li></ul></li></ul><h5>Arrange urgent assessment in secondary care</h5><ul><li>A UK clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Nathwani et al, 2008</a>] recommends that suspected serious and deep-seated MRSA infections (including suspected sepsis and pneumonia, osteomyelitis, abscesses, endocarditis) should be admitted to hospital for urgent assessment, investigations and intravenous antibiotics.</li></ul><h5>Treatment of uncomplicated infection</h5><ul><li>MRSA resistance, and policies on wound management and prescribing vary in different localities — advice should always be sought before prescribing antibiotics or initiating wound management.<ul><li>Clinical guidelines from the British Society for Antimicrobial Chemotherapy Working Party [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Nathwani et al, 2008</a>], the Department of Health (Ireland) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">An Roinn Slainte, 2013</a>] and Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">PHE, 2017</a>] recommend discussion with a microbiologist or the local infection control team regarding appropriate MRSA treatment (including topical antibiotics for mild skin infection).</li><li>Expert opinion from a reviewer of this CKS topic is that prescribing an inappropriate antibiotic for a person with MRSA infection could precipitate an invasive infection or encourage infection following carriage.</li></ul></li><li>Follow up — clinical guidance from the Centres for Disease Control [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">CDC, 2016</a>] and expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Ramakrishnan, 2015</a>] recommend follow up to monitor for signs of complications (such as sepsis) and ensure resolution of infection.</li></ul><h5>Decolonisation</h5><ul><li>Colonisation with MRSA may be long term and does not usually present a risk to other healthy people. Good hand hygiene and other standard infection control procedures should be followed by healthcare staff at all times to reduce the risk of transmission of infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Infection&nbsp;Prevention&nbsp;Control, 2017</a>].</li><li>The recommendation that decolonization is not routinely required for asymptomatic carriers of MRSA but may be indicated if risk factors are present (including admission to hospital) is based on the Department of Health expert advisory committee on Antimicrobial Resistance and Healthcare Associated Infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">ARHAI, 2014</a>] and clinical guidance [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Infection&nbsp;Prevention&nbsp;Control, 2017</a>].<ul><li>Information on risk of MRSA must be appropriately documented and communicated between healthcare agencies (for example, on transfer of a person with MRSA into hospital or long-term care facility) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Nathwani et al, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">An Roinn Slainte, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">CDC, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Infection&nbsp;Prevention&nbsp;Control, 2017</a>].</li><li>Discussion on the need for suppression therapy for cases of MRSA colonisation in the community should take place with the local infection-control team.</li><li>Screening swabs following suppression treatment are not routinely required for patients in the community but will typically be carried out by secondary care in the case of admission [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Infection&nbsp;Prevention&nbsp;Control, 2017</a>].</li></ul></li></ul><h5>Patient advice</h5><ul><li>Consensus opinion in clinical guidelines [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">Nathwani et al, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">An Roinn Slainte, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">CDC, 2016</a>] and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/mrsa-in-primary-care/references/\">BMJ Best Practice, 2018</a>] is that patient education is an important measure in the prevention of spread of MRSA.</li></ul><!-- end field 5f098d9a-b51d-4617-86f7-1d5c5a8482fb --><!-- end item 4807dd80-fd96-4132-9cb9-ad7560a043fd -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}